Skip to main content
Livermore
Livermore
ZHEN

Millennium Management LLC

SEC CIK
0001273087
Latest filing
Aug 14, 2026

SYRE holding history

Spyre Therapeutics, Inc. in every 13F filed by Millennium Management LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

SYRE overviewAll 13F holders of SYREFull Q2 2026 holdings

Shares (Q2 2026)
196,712
Value
$17.5M
% of portfolio
<0.1%
Quarters held
18
Since Q1 2021
Holdings of SYRE by Millennium Management LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026196,712$17.5M<0.1%+50,073+34.1%AddedHolders
Q1 2026146,639$7.40M<0.1%+70,445+92.5%AddedHolders
Q4 202576,194$2.50M<0.1%−332,005−81.3%ReducedHolders
Q3 2025408,199$6.84M<0.1%+408,199NewHolders
Q1 20250$00.0%−167,804−100.0%Sold outHolders
Q4 2024167,804$3.91M<0.1%+167,804NewHolders
Q2 20240$00.0%−319,563−100.0%Sold outHolders
Q1 2024319,563$12.1M<0.1%+211,077+194.6%AddedHolders
Q4 2023108,486$2.33M<0.1%+70,673+186.9%AddedHolders
Q3 202337,813$463.2K<0.1%−60,316−61.5%ReducedConverted for a 1-for-25 splitHolders
Q2 20232,453,221$1.11M<0.1%−1,283,262−34.3%ReducedHolders
Q1 20233,736,483$1.08M<0.1%+605,004+19.3%AddedHolders
Q4 20223,131,479$1.41M<0.1%+2,316,807+284.4%AddedHolders
Q3 2022814,672$429.0K<0.1%+292,757+56.1%AddedHolders
Q2 2022521,915$264.0K<0.1%+98,001+23.1%AddedHolders
Q1 2022423,914$975.0K<0.1%+233,432+122.5%AddedHolders
Q4 2021190,482$905.0K<0.1%−344,740−64.4%ReducedHolders
Q3 2021535,222$4.25M<0.1%−7,963−1.5%ReducedHolders
Q2 2021543,185$3.78M<0.1%+172,049+46.4%AddedHolders
Q1 2021371,136$2.94M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.